Bloom Tree Partners’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-193,199
Closed -$40.6M 34
2016
Q4
$40.6M Buy
193,199
+18,811
+11% +$3.9M 4.09% 7
2016
Q3
$40.2M Sell
174,388
-2,471
-1% -$604K 3.11% 12
2016
Q2
$40.9M Buy
176,859
+3,674
+2% +$847K 3.08% 14
2016
Q1
$46.4M Hold
173,185
4.21% 12
2015
Q4
$54.1M Buy
173,185
+24,702
+17% +$7.35M 5.21% 10
2015
Q3
$40.4M Buy
148,483
+2,820
+2% +$866K 3.8% 15
2015
Q2
$44.2M Buy
145,663
+14,960
+11% +$4.46M 4.01% 8
2015
Q1
$38.9M Buy
+130,703
New +$37.3M 4.22% 8

Other funds holding AGN

Bloom Tree Partners's AGN Position: Q1 2017 in Review

Bloom Tree Partners sold out of Allergan plc (AGN) in Q1 2017, closing a stake of 193,199 shares — an estimated $40.6M sold.

Bloom Tree Partners first reported a position in AGN in Q1 2015 and held it in 8 quarters. The position peaked at $54.1M in Q4 2015. 1,104 funds tracked by Wall St. Rank hold AGN as of Q1 2017.

  • Bloom Tree Partners reported no remaining Allergan plc position as of Q1 2017 after selling out during the quarter.
  • Bloom Tree Partners sold 193,199 Allergan plc shares in Q1 2017, an estimated $40.6M.
  • Bloom Tree Partners first reported a position in Allergan plc in Q1 2015 and held it in 8 quarters.
  • Bloom Tree Partners's Allergan plc position peaked at $54.1M in Q4 2015.
  • 1,104 funds tracked by Wall St. Rank held Allergan plc as of Q1 2017.

Based on Bloom Tree Partners's 13F filing for Q1 2017, filed 15 May 2017.